Graft-versus-host disease (GVHD) is a common - and potentially fatal - complication following bone marrow and solid organ transplants. This life threatening condition can also occur after a patient receives a blood transfusion or other forms of transplanted tissue from a genetically different person.
Traumatic brain injury (TBI) is one of the leading causes of death worldwide in individuals under the age of 45. Triggered by concussions from car accidents, falls, violent contact sports, explosives or by gunshot and stab wounds, TBI affects 1.7 million Americans annually. It is the most commonly identified cause of epilepsy among adults.
During the last week of June, more than 400 scientists from 25 countries met in Montreal for the 27th annual symposium of the International Cannabinoid Research Society (ICRS). Several presentations and posters showcased new findings about cannabidiol (CBD), the non-euphoric component of the cannabis plant that is transforming the medical marijuana landscape.
Scientists at the University of Louisville School of Medicine in Kentucky have identified a previously unknown molecular target of cannabidiol (CBD), which may have significant therapeutic implications for Parkinson’s Disease (PD).
The placebo effect happens when an expectation of benefit in a treatment creates the same response as an actual treatment. How does the power of thought influence the endocannabinoid system and our health?
Nishi Whiteley discusses the theme of cannabinoids and oxidation from her book “Chronic Relief: A Guide to Cannabis for the Terminally & Chronically Ill”. In the same way that paint protects metal from rusting or lemon juice protects apples from turning brown, cannabinoids protect our cells from oxidation.